Appeals Court Says Trump Administration Can’t Force Drugmakers to Disclose Prices

A federal appeals court ruled against the Trump administration on Wednesday, finding that it does not have the legal authority to mandate that drug manufacturers display the prices of their medicines in television advertisements.

Read More

Pandemic Forced Insurers To Pay For In-Home Treatments. Will They Disappear?

After seven days as an inpatient for complications related to heart problems, Glenn Shanoski was initially hesitant when doctors suggested in early April that he could cut his hospital stay short and recover at home — with high-tech 24-hour monitoring and daily visits from medical teams.

Read More

Moody’s: US Healthcare System Rebounds From COVID-19 in May, But a Bumpy Road Lies Ahead

Large sections of the healthcare sector all but shut down during the spring as the coronavirus led to nationwide shelter-in-place orders. However, as states and municipalities slowly reopen, so are the doors for hospitals, ambulatory surgical centers, clinics and other integral components of healthcare delivery.

Read More

Bipartisan Bills Aim To Prevent Price Gouging For Taxpayer-Funded COVID-19 Drugs

Two new bipartisan bills aim to prevent price gouging for taxpayer-funded treatments and vaccines for coronavirus disease 2019 (COVID-19).

Read More

How Unemployment Will Impact the Way We Access Health Insurance

The economic impact of job losses relating to COVID-19 will create a dramatic shift in how individuals access health insurance.

Read More

Insurers Should Prepare For ‘Volatile’ Individual Market Due To COVID-19 Pandemic: Study

The individual market next year is likely to be volatile due to the COVID-19 pandemic as new enrollees could cause adverse selection, a new report said.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square